VermaS,BainSC,BuseJBetal.Occurrence of First and Recurrent Major Adverse Cardiovascular Events With Liraglutide Treatment Among Patients With Type 2 Diabetes and High Risk of Cardiovascular Events: A Post Hoc Analysis of a Randomized Clinical Trial.JAMA Cardiol.2019;4(12):1214-20
Hingorani SR, Zheng L, Bullock AJ, Seery TE, Harris WP, Sigal DS, et al
Because PRP is derived from your own body, theres virtually no risk of allergic reaction or rejection
Future studies should develop more targeted therapies and optimize comprehensive management strategies to enhance patient outcomes and quality of life
While semaglutide remains the most common prescribed compounded molecule, the share of tirzepatide is increasing over time
NG145 Evidence C: Thyroid function tests